Welcome to LookChem.com Sign In|Join Free

Luhan Pharmachem Co., Lt

Free supplier Enterprise Certification

Free
supplier
3rd
years
Home>>Products>>Monosialoganglioside GM1,High Purity

Product Certification&
Enterprise Certification

More Detail

Luhan Pharmachem Co., Lt

Country: China (Mainland)

Business Type:Lab/Research institutions

Mr.liu

Tel: +86-871-65110906

Mobile: 86-131 6530761

Tel: +86-871-65110906

Fax:

URL: http://www.luhancn.com/

Province/state: Yunnan

City: Kunming

Street: Room702, Building 2, 365 Dianchi Road, Kunming, Yunnan Province, P.R. China

MaxCard:


Contact Suppliers

Monosialoganglioside GM1,High Purity

CAS NO.37758-47-7

Contact Supplier

Product Details

Keywords

  • Monosialoganglioside
  • GM-1
  • Monosialoganglioside

Quick Details

  • ProName: Monosialoganglioside GM1,High Purity
  • CasNo: 37758-47-7
  • Molecular Formula: C73H131N3O31
  • Appearance: White or almost white powder and liqui...
  • Application: Pharmaceutical intermediates
  • DeliveryTime: Negotiation
  • PackAge: 1kg/bag, 10kg/drum, 25kg/drum (on requ...
  • Port: Qingdao or other China port
  • ProductionCapacity: 1 Metric Ton/Month
  • Purity: 99.0%
  • Storage: Shading, airtight preservation
  • Transportation: By courier,by air,by sea
  • LimitNum: 1 Gram
  • Moisture Content: Enterprise standard
  • Impurity: Enterprise standard

Superiority

MONOSIALOGANGLIOSIDE(37758-47-7)                                                              

Information

The pharmacological mechanism of monosialoganglioside is to promote neural remodeling. It can improve the activity of nerve cell membranes, thereby reducing nerve cell edema and promoting the growth of nerve cell axons and synapses. Therefore, it can be used clinically to treat cerebrovascular diseases or central nervous system damage caused by brain trauma. It has a good recovery effect on paralysis caused by central nervous system damage, speech dysfunction and other symptoms. It can also be used to treat Parkinson's disease.

Treat nerve damage, neuropathy, neurological disorders. Brain-protecting drugs, nourish brain nerves, promote brain cell metabolism. It is used to treat hypoxia, ischemic encephalopathy, nerve damage of various traumatic and cardiovascular and cerebrovascular diseases, neonatal jaundice, neonatal hypoxia, ischemia, and neurological dysfunction in the late stage of various chronic diseases (such as the limbs in the late stage of diabetes Numbness), brain atrophy, Alzheimer's, intellectual disability, Parkinson's disease.

Quality

Advanced technology

Supper quality

Effective & safety package

Service

Professional and timely afte-sale service(replied within 12h)

COMPANY INFORMATION                                                                                 

Jinan Kangcheng Pharmaceutical Technology Co., Ltd.

Add:Jinan Area,China(Shandong) Pilot Free Trade Zone,China

The company focuses on the development and transfer of pharmaceutical technology. It is a modern enterprise integrating technology development, transfer and sales of APIs, pharmaceutical intermediates, and nutraceutical raw materials.

The company adheres to the principle of integrity and innovation, and provides customers with professional products and advanced technical services.

 

 

Details

MONOSIALOGANGLIOSIDE

Product information

English Name:Monosialoganglioside

English Alias:Sygen;Ganglioside M1;GM1;

Monosialotetrahexosylganglioside Sodium;

Ganglioside GM1 (Ovine Brain)

Chinese Name:单唾液神经节苷脂

Chinese Name:单唾液酸神经节苷酯GM1;

神经节苷酯 M1;

单唾液神经节苷酯(-20℃);

单唾液酸四己糖神经节苷脂

CAS:37758-47-7     

Formula:C73H131N3O31

Molecular weight:1563.85

Appearane:White or off-white crystalline power

Purity:99.0%

Use&Pharmacology

Gangliosides have a significant effect on nerve regeneration. Single salivary gangliosides can promote the recovery of nerve function after central nervous system damage caused by various reasons. The mechanism of action is to promote nerve remodeling (including the survival of nerve cells, axis Synapse growth and synapse production). It has a protective effect on secondary neurodegeneration after injury, can improve cerebral hemodynamic parameters and reduce brain edema after injury, and can also improve behavioral disorders caused by Parkinson's disease.

Dosage

20-40mg a day, once or divided intramuscularly or slowly intravenously. In the acute phase of the disease (especially acute trauma), 100 mg daily, intravenous drip, 2 to 3 weeks later, change to maintenance dose, 20 to 40 mg daily, usually 6 weeks。

Adverse reactions

The adverse reaction of single salivary ganglioside is mainly a rash reaction after use.

Package&Storage

Package:1kg/bag, 10kg/drum, 25kg/drum (on request)

Storage&Validity:Cool, shading, dry and sealed/2years

 

 

Hot Product